Silver Book Fact

Growth hormone treatment in patients with fibromyalgia is effective in reducing pain with sustained action over time.

Cuatrecasas G, Alegre C, Fernandez-Sola J, et al. Growth Hormone Treatment for Sustained Pain Reduction and Improvement in Quality of Life in Severe Fibromyalgia. Pain. 2012; 153(7): 1382-9. http://www.ncbi.nlm.nih.gov/pubmed/22465047

Reference

Title
Growth Hormone Treatment for Sustained Pain Reduction and Improvement in Quality of Life in Severe Fibromyalgia
Publication
Pain
Publication Date
2012
Authors
Cuatrecasas G, Alegre C, Fernandez-Sola J, et al
Volume & Issue
Volume 153, Issue 7
Pages
1382-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Topical capsaicin was found in a meta-analysis to provide a degree of pain relief to some patients with painful neuropathic conditions.  
  • Use of stem cells to create neurons could enable the study of the response of human cells to new drugs in vitro, early in the drug development process.  
  • Targeting A-type K+ channels in primary sensory neurons could provide a novel mechanism-based therapy for the treatment of bone cancer pain–one of the most severe types of chronic pain.  
  • The combination of information for neuroimaging and circulatory biomarkers could improve both the sensitivity and specificity of pain diagnosis and thereby improve treatment.  
  • In individuals with persistent low back pain, tanezumab, a humanized anti-nerve growth factor antibody, showed clinical and statistical analgesic efficacy that was superior to placebo and naproxen.